Canton Strategic Holdings CNTN
NASDAQ CNTN
$2.28 +0.03 (+1.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

Canton Strategic Holdings (CNTN) Interest Expenses (2021 - 2025)

Canton Strategic Holdings' (CNTN) quarterly Interest Expenses came in at $4065.0 in Q4 2025, up 436.28% YoY from $758.0 in Q4 2024, and down 57.87% on a QoQ basis from $9648.0 in Q3 2025.

Analysis

Canton Strategic Holdings (CNTN) Interest Expenses (2021 - 2025) Analysis & Trends

Canton Strategic Holdings (CNTN) has 6 years of Interest Expenses data on file, last reported at $4065.0 in Q4 2025.

  • Quarterly Interest Expenses rose 436.28% year-over-year to $4065.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $19874.0 (up 13.86% YoY) and the FY2025 annual result came in at $5.1 million, down 50.15% from the prior year.
  • Interest Expenses slipped to $4065.0 in Q4 2025, from $9648.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $1.6 million in Q1 2022 to a low of -$1.6 million in Q4 2022.
  • A 5-year average of $47998.2 and a median of $6138.0 in 2023 frame the typical range for Interest Expenses.
  • The widest YoY moves for Interest Expenses: up 979.69% in 2022, down 708.14% in 2022.
  • Tracing CNTN's Interest Expenses over 5 years: stood at $258000.0 in 2021, then plunged by 708.14% to -$1.6 million in 2022, then soared by 100.02% to $354.0 in 2023, then surged by 114.12% to $758.0 in 2024, then surged by 436.28% to $4065.0 in 2025.
  • The last three Interest Expenses figures came in at $4065.0 (Q4 2025), $9648.0 (Q3 2025), and $6161.0 (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 11.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -1.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 23.78 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 39.74 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 82.05 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 93.62 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 20.27 Mn
10 Canton Strategic Holdings 493.37 Mn 493.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 4,065.00
Sep 30, 2025 9,648.00
Jun 30, 2025 6,161.00
Mar 31, 2025 8,471.00
Dec 31, 2024 758.00
Sep 30, 2024 3,009.00
Jun 30, 2024 5,217.00
Mar 31, 2024 4,700.00
Dec 31, 2023 354.00
Sep 30, 2023 3,496.00
Jun 30, 2023 6,517.00
Mar 31, 2023 6,138.00
Dec 31, 2022 -8,756.00
Mar 31, 2022 1.60 Mn
Dec 31, 2021 258,277.00
Sep 30, 2021 236,000.00
Jun 30, 2021 189,000.00
Mar 31, 2021 148,190.00